Diffuse large B-cell lymphoma of the uterine cervix

A rare case managed novelly

Gunjan Baijal, B. Vadiraja, Donald Fernandes, M. Vidyasagar

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Non-Hodgkin′s lymphoma (NHL) of the uterine cervix is exceedingly rare. The management of the disease is not standardized. A 44-year-old lady presented with a history of bleeding pervaginum and a foul-smelling discharge of 2 months′ duration. A 7 x 7 growth was seen in the cervix. A biopsy revealed it to be a CD20-positive diffuse large B-cell (DLBCL)-type NHL. She was diagnosed as stage IE after staging work-up, and managed with three courses of rituximab, cyclophosphamide, vincristine, adriamycin, and prednisolone followed by external beam radiotherapy (46 Gy in 23 fractions) by 3D conformal technique. She attained a complete response, and has been in remission for 1 year 3 months.

Original languageEnglish
Pages (from-to)140-142
Number of pages3
JournalJournal of Cancer Research and Therapeutics
Volume5
Issue number2
DOIs
Publication statusPublished - 01-04-2009

Fingerprint

Lymphoma, Large B-Cell, Diffuse
Cervix Uteri
Non-Hodgkin's Lymphoma
Vincristine
Disease Management
Prednisolone
Doxorubicin
Cyclophosphamide
B-Lymphocytes
Radiotherapy
Hemorrhage
Biopsy
Growth
Rituximab

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Baijal, Gunjan ; Vadiraja, B. ; Fernandes, Donald ; Vidyasagar, M. / Diffuse large B-cell lymphoma of the uterine cervix : A rare case managed novelly. In: Journal of Cancer Research and Therapeutics. 2009 ; Vol. 5, No. 2. pp. 140-142.
@article{9ff32c434293436dbdc03763c4a036e1,
title = "Diffuse large B-cell lymphoma of the uterine cervix: A rare case managed novelly",
abstract = "Non-Hodgkin′s lymphoma (NHL) of the uterine cervix is exceedingly rare. The management of the disease is not standardized. A 44-year-old lady presented with a history of bleeding pervaginum and a foul-smelling discharge of 2 months′ duration. A 7 x 7 growth was seen in the cervix. A biopsy revealed it to be a CD20-positive diffuse large B-cell (DLBCL)-type NHL. She was diagnosed as stage IE after staging work-up, and managed with three courses of rituximab, cyclophosphamide, vincristine, adriamycin, and prednisolone followed by external beam radiotherapy (46 Gy in 23 fractions) by 3D conformal technique. She attained a complete response, and has been in remission for 1 year 3 months.",
author = "Gunjan Baijal and B. Vadiraja and Donald Fernandes and M. Vidyasagar",
year = "2009",
month = "4",
day = "1",
doi = "10.4103/0973-1482.52784",
language = "English",
volume = "5",
pages = "140--142",
journal = "Journal of Cancer Research and Therapeutics",
issn = "0973-1482",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "2",

}

Diffuse large B-cell lymphoma of the uterine cervix : A rare case managed novelly. / Baijal, Gunjan; Vadiraja, B.; Fernandes, Donald; Vidyasagar, M.

In: Journal of Cancer Research and Therapeutics, Vol. 5, No. 2, 01.04.2009, p. 140-142.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Diffuse large B-cell lymphoma of the uterine cervix

T2 - A rare case managed novelly

AU - Baijal, Gunjan

AU - Vadiraja, B.

AU - Fernandes, Donald

AU - Vidyasagar, M.

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Non-Hodgkin′s lymphoma (NHL) of the uterine cervix is exceedingly rare. The management of the disease is not standardized. A 44-year-old lady presented with a history of bleeding pervaginum and a foul-smelling discharge of 2 months′ duration. A 7 x 7 growth was seen in the cervix. A biopsy revealed it to be a CD20-positive diffuse large B-cell (DLBCL)-type NHL. She was diagnosed as stage IE after staging work-up, and managed with three courses of rituximab, cyclophosphamide, vincristine, adriamycin, and prednisolone followed by external beam radiotherapy (46 Gy in 23 fractions) by 3D conformal technique. She attained a complete response, and has been in remission for 1 year 3 months.

AB - Non-Hodgkin′s lymphoma (NHL) of the uterine cervix is exceedingly rare. The management of the disease is not standardized. A 44-year-old lady presented with a history of bleeding pervaginum and a foul-smelling discharge of 2 months′ duration. A 7 x 7 growth was seen in the cervix. A biopsy revealed it to be a CD20-positive diffuse large B-cell (DLBCL)-type NHL. She was diagnosed as stage IE after staging work-up, and managed with three courses of rituximab, cyclophosphamide, vincristine, adriamycin, and prednisolone followed by external beam radiotherapy (46 Gy in 23 fractions) by 3D conformal technique. She attained a complete response, and has been in remission for 1 year 3 months.

UR - http://www.scopus.com/inward/record.url?scp=67749120838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67749120838&partnerID=8YFLogxK

U2 - 10.4103/0973-1482.52784

DO - 10.4103/0973-1482.52784

M3 - Article

VL - 5

SP - 140

EP - 142

JO - Journal of Cancer Research and Therapeutics

JF - Journal of Cancer Research and Therapeutics

SN - 0973-1482

IS - 2

ER -